UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

An update on the pathological classification of breast cancer

Histopathology, 2023-01, Vol.82 (1), p.5-16

2023

Volltextzugriff (PDF)

Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls

Histopathology, 2024-04, Vol.84 (5), p.723-741

2024

Volltextzugriff (PDF)

Adenomyoepithelioma of the breast: a proposal for classification

Histopathology, 2021-10, Vol.79 (4), p.465-479

2021

Volltextzugriff (PDF)

Apocrine lesions of the breast

Virchows Archiv : an international journal of pathology, 2022-01, Vol.480 (1), p.177-189

2022

Volltextzugriff (PDF)

Human Epidermal Growth Factor Receptor 2 Testing by Fluorescent In Situ Hybridization: Positive or Negative? ASCO/College of American Pathologists Guidelines 2007, 2013, and 2018

Journal of clinical oncology, 2018-12, Vol.36 (35), p.JCO1800788-3523

2018

Volltextzugriff (PDF)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis

Cancers, 2021-11, Vol.13 (22), p.5694

2021

Volltextzugriff (PDF)

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer

Modern pathology, 2021-07, Vol.34 (7), p.1271-1281

2021

Volltextzugriff (PDF)

Human Epidermal Growth Factor Receptor 2 Testing by Fluorescent In Situ Hybridization: Positive or Negative? American Society of Clinical Oncology/College of American Pathologists Guidelines 2007, 2013, and 2018

Archives of pathology & laboratory medicine (1976), 2019-04, Vol.143 (4), p.412-413

2019

Volltextzugriff (PDF)

Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinoma

Virchows Archiv : an international journal of pathology, 2020-03, Vol.476 (3), p.367-372

2020

Volltextzugriff (PDF)

Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Histopathology, 2024-09, Vol.85 (3), p.418-436

2024

Volltextzugriff (PDF)

Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance

Histopathology, 2022-02, Vol.80 (3), p.515-528

2022

Volltextzugriff (PDF)

A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Histopathology, 2024-06, Vol.84 (7), p.1111-1129

2024

Volltextzugriff (PDF)

Fine-Needle Aspiration Biopsy Management of the Axilla in Primary Breast Carcinoma

Acta cytologica, 2019-01, Vol.63 (4), p.314-318

2019

Volltextzugriff (PDF)

Atypia in breast pathology: what pathologists need to know

Pathology, 2022-02, Vol.54 (1), p.20-31

2022

Volltextzugriff (PDF)

Reporting of Surgically Removed Lymph Nodes for Breast Tumors: Recommendations From the International Collaboration on Cancer Reporting

Archives of pathology & laboratory medicine (1976), 2022-11, Vol.146 (11), p.1308-1318

2022

Volltextzugriff (PDF)

Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases

British journal of cancer, 2021-05, Vol.124 (11), p.1836-1842

2021

Volltextzugriff (PDF)

The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer

Histopathology, 2022-10, Vol.81 (4), p.511-519

2022

Volltextzugriff (PDF)

Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study

Breast cancer research and treatment, 2020-10, Vol.183 (3), p.759-770

2020

Volltextzugriff (PDF)

Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland

Current oncology (Toronto), 2024-03, Vol.31 (3), p.1302-1310

2024

Volltextzugriff (PDF)

Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management

Histopathology, 2021-04, Vol.78 (5), p.759-771

2021

Volltextzugriff (PDF)

Management of the axilla post‐neoadjuvant chemotherapy in node positive breast cancer: Can the combination of axillary ultrasound and tumor biomarkers improve patient selection for sentinel node biopsy?

The breast journal, 2021-04, Vol.27 (4), p.394-396

2021

Volltextzugriff (PDF)

Development and use of health outcome descriptors: a guideline development case study

Health and quality of life outcomes, 2020-06, Vol.18 (1), p.1-167, Article 167

2020

Volltextzugriff (PDF)

Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node‐negative breast cancer patients

The FEBS journal, 2015-09, Vol.282 (18), p.3455-3473

2015

Volltextzugriff (PDF)

Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer

Virchows Archiv : an international journal of pathology, 2017-09, Vol.471 (3), p.321-328

2017

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Englisch
(135)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

An update on the pathological classification of breast cancer

Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls

Adenomyoepithelioma of the breast: a proposal for classification

Apocrine lesions of the breast

Human Epidermal Growth Factor Receptor 2 Testing by Fluorescent In Situ Hybridization: Positive or Negative? ASCO/College of American Pathologists Guidelines 2007, 2013, and 2018

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer

Human Epidermal Growth Factor Receptor 2 Testing by Fluorescent In Situ Hybridization: Positive or Negative? American Society of Clinical Oncology/College of American Pathologists Guidelines 2007, 2013, and 2018

Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinoma

Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance

A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Fine-Needle Aspiration Biopsy Management of the Axilla in Primary Breast Carcinoma

Atypia in breast pathology: what pathologists need to know

Reporting of Surgically Removed Lymph Nodes for Breast Tumors: Recommendations From the International Collaboration on Cancer Reporting

Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases

The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer

Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study

Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland

Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland –on behalf of the UK national coordinating committee for breast pathology

Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management

Management of the axilla post‐neoadjuvant chemotherapy in node positive breast cancer: Can the combination of axillary ultrasound and tumor biomarkers improve patient selection for sentinel node biopsy?

Development and use of health outcome descriptors: a guideline development case study

Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node‐negative breast cancer patients

Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer

Suchergebnisse filtern